Recs

1
Player Avatar MagicDiligence (< 20) Submitted: 8/13/2010 9:18:35 AM : Outperform Start Price: $13.15 VPHM.DL Score: +57.42

ViroPharma markets two drugs: Vancocin for clostridium difficile infections, and Cinryze for rare hereditary angioedema. The company's investment potential is tied to how fast the latter can replace declining sales from the former.Read my full CAPS review here:http://caps.fool.com/Blogs/viropharma-vphm-a-tale-of/433135

Featured Broker Partners


Advertisement